EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ultrasound-Guided Axillary Management in Early-Stage Breast Cancer: From Diagnosis to De-Escalation

Xiangmin Shen, Zi Yi, Kui Tang iD

Cancers · 26.07.2026 · 18 (15) · 2405

DOI: 10.3390/cancers18152405 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 26.07.2026. Verfasst von Xiangmin Shen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha 410011, China. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Axillary lymph node management in early-stage breast cancer has undergone a fundamental transformation over the past three decades, shifting from routine radical clearance to precision-guided de-escalation. Ultrasound (US) has emerged as the central imaging modality in this paradigm shift, serving as the first-line tool for preoperative nodal assessment, guidance for biopsy and clip placement, monitoring of response to neoadjuvant chemotherapy (NAC), and localization of marked nodes for targeted axillary dissection (TAD). This review systematically examines the evolution of axillary management in early-stage breast cancer through a US-centric lens. We summarize the historical transition from Halstedian axillary lymph node dissection (ALND) to sentinel lymph node biopsy (SLNB), critically appraise the landmark trials—Z0011, AMAROS, OTOASOR, and SOUND—that have progressively de-escalated axillary surgery, and detail the role of US in preoperative staging (including conventional B-mode, superb microvascular imaging, contrast-enhanced US, elastography, and AI-assisted diagnostics), US-guided biopsy and node marking, and post-NAC TAD. We further explore the integration of US with liquid biopsy, multigene profiling, and molecular subtype-guided systemic therapy to enable individualized decision-making. Finally, we propose a stepwise US-centric clinical algorithm and discuss future directions, including AI-powered real-time interpretation, imaging-omics, and US-guided targeted therapy. This review provides a comprehensive framework for incorporating ultrasound as a key component of multidisciplinary decision-making—alongside pathological, surgical, radiotherapeutic, and molecular inputs—in contemporary axillary management.

Schlagwörter

Stichwörter der Autor:innen

axillary lymph nodebreast cancerde-escalation therapyneoadjuvant chemotherapysentinel lymph node biopsytargeted axillary dissectionultrasound

Autor:innen und Institutionen

  • Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
  • Department of Cardiovascular Surgery Intensive Care Unit, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
  • Department of Ultrasound Diagnosis, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
  • Research Center of Ultrasonography, The Second Xiangya Hospital of Central South University, Changsha 410011, China.

ORCID-Profile: Kui Tang

Zitieren

APA

Shen, X., Yi, Z., & Tang, K. (2026). Ultrasound-Guided Axillary Management in Early-Stage Breast Cancer: From Diagnosis to De-Escalation. Cancers, 18(15), 2405. https://doi.org/10.3390/cancers18152405

Vancouver

Shen X, Yi Z, Tang K. Ultrasound-Guided Axillary Management in Early-Stage Breast Cancer: From Diagnosis to De-Escalation. Cancers. 2026;18(15):2405. doi:10.3390/cancers18152405

BibTeX
@article{Shen2026,
  author = {Shen, Xiangmin and Yi, Zi and Tang, Kui},
  title = {Ultrasound-Guided Axillary Management in Early-Stage Breast Cancer: From Diagnosis to De-Escalation},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {15},
  pages = {2405},
  doi = {10.3390/cancers18152405}
}
Kostenlos starten →